Truitt Joseph
Insider CIK 1452429 · ACHN SVP, Chief Commercial Officer, Director · LRMR Director · IPSC Director · BSTC Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IPSC Century Therapeutics, Inc. | A Award deriv | 2026-09-09 | 2026-09-10 | 148,000 | — | $0 | 148,000 | SEC↗ |
| IPSC Century Therapeutics, Inc. | A Award deriv | 2026-09-09 | 2026-09-10 | 148,000 | — | $0 | 148,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-05-19 | 2026-05-20 | 55,150 | — | $0 | 55,150 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-05-13 | 2025-05-14 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-05-29 | 2024-05-31 | 19,000 | — | $0 | 19,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2023-05-17 | 2023-05-18 | 2,750 | $3.73 | $10.3K | 2,750 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-05-09 | 2023-05-11 | 8,300 | — | $0 | 8,300 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2022-05-10 | 2022-05-12 | 8,300 | — | $0 | 8,300 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2021-05-12 | 2021-05-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | D To issuer deriv | 2020-12-02 | 2020-12-02 | 100,000 | $24.78 | $2.48M | 0 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2020-09-29 | 2020-09-30 | 16,600 | — | $0 | 16,600 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | A Award deriv | 2020-05-28 | 2020-10-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| BSTC BIOSPECIFICS TECHNOLOGIES | A Award deriv | 2020-05-28 | 2020-05-29 | 130,000 | — | $0 | 130,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 632,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 185,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 100,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 142,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 200,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 419,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 1,097,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 30,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer deriv | 2020-01-28 | 2020-01-29 | 87,766 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | D To issuer | 2020-01-28 | 2020-01-29 | 3,500 | $6.30 | $22.1K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2019-10-16 | 2019-10-18 | 100,234 | — | $0 | 87,766 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2019-10-16 | 2019-10-18 | 33,250 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2019-10-16 | 2019-10-18 | 100,234 | $6.37 | $638.5K | 36,750 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2019-10-16 | 2019-10-18 | 33,250 | $3.28 | $109.1K | 136,984 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2019-10-16 | 2019-10-18 | 100,234 | $3.10 | $310.7K | 103,734 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2019-10-16 | 2019-10-18 | 33,250 | $6.37 | $211.8K | 3,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2019-01-23 | 2019-01-25 | 1,097,000 | — | $0 | 1,097,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-05-01 | 2018-05-03 | 632,000 | — | $0 | 632,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2018-02-09 | 2018-02-13 | 419,000 | — | $0 | 419,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2017-01-17 | 2017-01-19 | 185,000 | — | $0 | 185,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | P Buy | 2016-12-02 | 2016-12-05 | 3,500 | $4.06 | $14.2K | 3,500 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2016-01-20 | 2016-01-22 | 142,000 | — | $0 | 142,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-12-02 | 2014-12-04 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-08-25 | 2014-08-26 | 25,000 | — | $0 | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-08-25 | 2014-08-26 | 25,000 | $0.82 | $20.5K | 25,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-08-25 | 2014-08-26 | 25,000 | $10.82 | $270.5K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-06-16 | 2014-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-16 | 2014-06-17 | 25,000 | $7.82 | $195.5K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-06-16 | 2014-06-17 | 25,000 | $0.82 | $20.5K | 25,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-06-10 | 2014-06-11 | 48,950 | — | $0 | 50,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-10 | 2014-06-11 | 48,950 | $6.05 | $296.1K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-06-10 | 2014-06-11 | 48,950 | $0.82 | $40.1K | 48,950 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise deriv | 2014-06-09 | 2014-06-11 | 1,050 | — | $0 | 98,950 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | S Sale | 2014-06-09 | 2014-06-11 | 1,050 | $4.82 | $5.1K | 0 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | M Exercise | 2014-06-09 | 2014-06-11 | 1,050 | $0.82 | $861 | 1,050 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2014-03-04 | 2014-03-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2013-12-17 | 2013-12-19 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ACHN ACHILLION PHARMACEUTICALS | A Award deriv | 2012-12-18 | 2012-12-20 | 145,000 | — | $0 | 145,000 | SEC↗ |